Streetbeat News

Price Targets

AAPL

Apple's M3 Pro MacBook Pro 14-inch with 36GB RAM is available for a record-low price of $1,999 after a $400 discount using an exclusive coupon code APINSIDER at Adorama. The offer also includes a $50 discount on three years of AppleCare. The deal is expected to be popular and inventory may be limited, with units expected to ship on Dec. 30.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 3:51 pm

NPCE

NeuroPace (NASDAQ:NPCE) has received mixed analyst ratings over the past quarter, with a recent shift towards a more bullish outlook. The average 12-month price target is now $9.67, up 27.24% from the previous $7.60, with a high estimate of $12.00 and a low of $8.00. Analysts from firms including Lake Street, Morgan Stanley, Cantor Fitzgerald, JP Morgan, and Wells Fargo have maintained or raised their ratings and price targets. NeuroPace is a medical device company with significant revenue growth and market capitalization but faces challenges with net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 3:00 pm

LYFT

Lyft (NASDAQ:LYFT) has been evaluated by 6 analysts over the last three months, with a mix of indifferent (5) and bearish (1) ratings. The average 12-month price target for Lyft is $11.08, up from $10.80, with a high estimate of $14.00 and a low of $7.00. Analysts from firms including Wedbush, Morgan Stanley, Truist Securities, Wells Fargo, and MoffettNathanson have updated their price targets and ratings, with most maintaining a neutral stance and one issuing a sell rating. Lyft's financials show a positive revenue trend with a growth rate of 9.84% as of September 30, 2023, but a lower growth rate compared to the Industrials sector average. The company has an exceptional net margin of -1.05%, an impressive ROE of -2.83%, and an ROA of -0.27%, with a debt-to-equity ratio of 2.23.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 3:00 pm

CVRX

Lake Street analyst Frank Takkinen has maintained a Buy rating on CVRx (NASDAQ:CVRX) and increased the price target from $21 to $32.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 2:33 pm

TELA

Lake Street analyst Frank Takkinen has reiterated a Buy rating on TELA Bio (NASDAQ:TELA) and maintained a $14 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 2:31 pm

NPCE

Lake Street analyst Frank Takkinen has reiterated a Buy rating on NeuroPace (NASDAQ:NPCE) and maintained a $12 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 2:29 pm

IOVA

HC Wainwright & Co. analyst Joseph Pantginis has maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) but reduced the price target from $38 to $28. This adjustment reflects a more conservative valuation of the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 2:24 pm

LYFT

Wedbush analyst Daniel Ives has maintained a Neutral rating on Lyft (NASDAQ:LYFT) and increased the price target from $12 to $14.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 2:10 pm

CART

Wedbush analyst Scott Devitt has maintained a Neutral rating on Maplebear (NASDAQ:CART) but has lowered the price target from $30 to $26.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 2:08 pm